Strides Arcolab surges on plan to sell Australian branded-generics unit

09 Jan 2012 Evaluate

Strides Arcolab is currently trading at Rs 401.10, up by 6.35 points or 1.61% from its previous closing of Rs 394.45 on the BSE.

The scrip opened at Rs 399.10 and has touched a high and low of Rs 407.80 and Rs 397.10 respectively. So far 4536 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 438.85 on 12-Jan-2011 and a 52 week low of Rs 276.25 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs 409.50 and Rs 387.20 respectively. The current market cap of the company is Rs 2341.92 crore.

The promoters holding in the company stood at 28.43% while Institutions and Non-Institutions held 52.90% and 18.68% respectively. 

Strides Arcolab, the Indian drug maker is likely to sell its Australian branded-generics unit, Ascent Pharmahealth. The company is also considering the divestment of other businesses such as softgel and anti-retro viral drug manufacturing, as the drug maker wants to focus on specialty injectables. US investment bank Jefferies and Co is advising Strides Arcolab for the divestments.

Ascent Pharmahealth is one of the largest branded generic drugmakers in Australia, with 13% market share. It also has a significant presence in Singapore, Thailand and Vietnam. In 2010, the business had sales of $140 million.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×